Development of dipeptidyl peptidase-4 inhibitors
Автор:
Jesse Russell,Ronald Cohn, 104 стр., издатель:
"Книга по Требованию", ISBN:
978-5-5093-6396-2
High Quality Content by WIKIPEDIA articles! Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) are enzyme inhibitors that inhibit the enzyme dipeptidyl peptidase-4 (DPP-4) and are a potent treatment for type 2 diabetes. Inhibition of the DPP-4 enzyme prolongs and enhances the activity of incretins that play an important role in insulin secretion and blood glucose control regulation. Type 2 diabetes is a chronic metabolic disease that can be caused by pancreas ?-cell dysfunction, deficiency in insulin secretion, insulin resistance and/or increased hepatic glucose production. It is one of the fastest growing health concerns in the world. Current treatments are often inefficient at sustaining glycemic control and may cause undesirable side effects, such as weight gain and episodes of hypoglycemia. Therefore, new and more effective drugs have been developed with DPP-4 inhibitors playing a significant role. Данное издание представляет собой компиляцию сведений, находящихся в свободном...
Рейтинг книги:



4 из 5,
7 голос(-ов).